Foreword
Patterns of biological therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists' Biologic Interventions Register : O01
Medication beliefs are associated with medication adherence in patients with psoriasis using systemic therapies: findings from the Investigating Medication Adherence in Psoriasis study : O02
The primary-care management of hidradenitis suppurativa in the U.K.: an evaluation of patient pathways and healthcare resource use using The Health Improvement Network database : O03
The Patient-Oriented Eczema Measure of eczema severity in young children: responsiveness and minimal clinically important difference : O04
Doxycycline vs. prednisolone for initial treatment of bullous pemphigoid: a pragmatic noninferiority randomized controlled trial : O05
Preliminary results of a randomized controlled trial of silk therapeutic clothing for the management of eczema in children (CLOTHES Trial) : O06
Assessment of human leucocyte antigen Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis : O07
Risk of serious infections in patients with psoriasis on biological therapies: a systematic review and meta-analysis : O08
British Association of Dermatologists national audit on nonmelanoma skin cancer excision 2014 : O09
Chemoprevention of cutaneous squamous cell carcinoma with acitretin in renal transplant recipients: a case-control analysis : O10
Clinical and immunological outcomes of treatment with rituximab vs. combination of rituximab and intravenous cyclophosphamide in treatment of refractory pemphigus: a pilot randomized double-blind study : O11
Combination of follicular and epidermal cell suspension as a novel surgical approach in acral vitiligo: a randomized controlled study : O12
Leprosy in Kiribati: understanding the challenges and progress towards eradication : O13
Owning cats or dogs is associated with protection from food allergy and increased diversity of infants' faecal microbiota at 3 months : RF01
Horizon planning for nonmelanoma skin cancer in the U.K.: estimated cases for 2020 and 2025 : RF02
‘Psoriasis direct’ service : RF03
Investigating lymph node involvement in mycosis fungoides: optimizing the balance between benefit and harm : RF04
Adult-onset folliculocentric Langerhans cell proliferation of uncertain malignant potential : CPC01
A tropical ‘mole’ : CPC02
Systemic lupus erythematosus presenting with a neutrophilic dermatosis : CPC03
Papuloerythroderma of Ofuji: sitting on the deck of the bay : CPC04
Tattoo-like macular blue skin lesions in a tyre factory worker exposed to carbon black : CPC05
Visage mauve : CPC06
A dramatically different case of Dowling-Degos disease : CPC07
Acrodermatitis acidaemia: a rash mimicking acrodermatitis enteropathica in a patient with methylmalonic acidaemia : CPC08
Angioimmunoblastic T-cell lymphoma masquerading as drug reaction with eosinophilia and systemic symptoms : CPC09
A case of Happle-Tinschert syndrome with previously unreported phenotypic abnormalities : CPC10
A vesiculobullous crusted eruption in a quadriplegic long-term-care patient : CPC11
Postirradiation atypical vascular proliferation following breast-conserving therapy for breast carcinoma : CPC12
‘Once bitten, twice shy’: mosquito bite hypersensitivity and Epstein-Barr virus reactivation associated with non-Hodgkin lymphoma : CPC13
Delayed oral toxicity from BRAF-targeted therapy : CPC14
Disseminated Mycobacterium marinum infection : P01
Cutaneous amyloid deposition following a lichenoid drug eruption : P02
Persistent and progressive purpura in a patient on long-term care : P03
Sweet syndrome-pyoderma gangrenosum overlap as a presenting symptom of acute Crohn colitis in a patient with seronegative spondyloarthropathy : P04
Cutaneous features of granulomatosis with polyangiitis presenting after diagnosis of systemic disease and during maintenance therapy with azathioprine : P05
Idiopathic palisaded neutrophilic and granulomatous dermatitis : P06
Abstract withdrawn. P08 Metastatic epithelioid angiosarcoma : P07
A novel triad: invasive dermatophyte infection with Trichophyton interdigitale , acquired reactive perforating collagenosis and associated signal transducer and activator of transcription 3 mutation : P09
A long-standing nodule on the chin: could it be a squamous cell carcinoma? : P10
Disseminated tuberculosis masquerading as a nonhealing oral ulcer : P11
Pruritic translucent papules, joint pains and giant cells: a case of multicentric reticulohistiocytosis : P12
Squamous transformation in cutaneous Crohn disease : P13
Reticular erythematous mucinosis: two cases treated with mepacrine : P14
Paraneoplastic cherry angiomata : P15
A hole in one: a case of severe unilateral vulval ulceration in a young woman : P16
Cutaneous angiosarcoma of the chest wall post-trauma : P17
A case of genital pyoderma gangrenosum successfully treated with ciclosporin without relapse of established follicular lymphoma, and a review of relevant existing literature : P18
A suppurative infection with subsequent scarring: possibly the first reported case of canine-to-human transmission of Trichophyton mentagrophytes var. erinacei : P19
Rosai-Dorfman disease: successful treatment with methotrexate : P20
Malignant peripheral nerve sheath tumour presenting in neurofibromatosis type 1 : P21
Prescribing for acne in the U.K.: patterns and influencers : P22
Is there a dermatologist in the house? A 1-year review of dermatology inpatient activity in a district general hospital : P23
Evaluation of the IMPACT study practitioner training intervention: using motivational interviewing to optimize self-management in psoriasis : P24
Proposal for National Dermatology Surgery Safety Standards: development of a dermatology surgery standard operating policy with mandatory training of staff may be an important tool to prevent wrong-site surgery : P25
The Facebook effect: using digital technology and social media to increase research participation from teenagers and healthcare professionals : P26
Detecting psoriatic arthritis in patients with psoriasis: does an educational leaflet improve attendance for screening? : P27
The future for general practitioners' dermatology education: what GPs want : P28
Eczema education via video: an online survey : P29
Interruptions: are they always appropriate? : P30
Dermatology seasonal flux: does it really exist? : P31
The dermatology clinic checklist: improving efficiency in a busy teaching hospital : P32
How to map the Dermatology Life Quality Index to EQ-5D domain scores for cost-effective analysis: an ordinal logistic regression model : P33
Dermatology-led lower-limb cellulitis service: analysis of 1579 referrals : P34 (PP01)
Spontaneous regression of skin lesions. What have I missed? : P35 (PP02)
How scratching can take its Toll on itch: new mechanistic insights into innate immune pathways, via Toll-like receptor 3 in peripheral itch sensitization : P36 (PP03)
Severe cutaneous drug hypersensitivity reactions to vancomycin and teicoplanin : P37 (PP04)
Impact of biological therapies on risk of major adverse cardiac events in patients with psoriasis: a meta-analysis of randomized controlled trials : P38
Fatal disseminated cowpox virus infection in an immunosuppressed adolescent : P39
Chronic inflammatory conditions carry a similarly higher cardiovascular risk compared with the general population and warrant screening : P40
Hansen disease: a biochemical perspective and insight into the role of antioxidants : P41
The profile and secondary-care management of U.K. patients with hidradenitis suppurativa: interim results from a multicentre observational cross-sectional study : P42
Spectrum of granuloma annulare: a retrospective clinicopathological study : P43
A dynamic landscape of allergen associations in delayed-type cutaneous hypersensitivity : P44
Impact of alexithymia and disease characteristics on work productivity and activity in patients with psoriasis with short disease duration: EPIDEPSO multicentre study : P45
Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective study of epidemiology and clinical course : P46
Frontal fibrosing alopecia in men: an association with leave-on facial cosmetics and sunscreens : P47
Can the new CONTEST questionnaire identify psoriatic arthritis in patients with psoriasis in a primary-care population? : P48
Twenty-year review of congenital absence of skin presenting to a paediatric dermatology department : P49
Vulvovaginal symptoms in women with epidermolysis bullosa : P50
Insulin resistance and metabolic syndrome in acne : P51
Psoriasis and carotid artery intima-media thickness : P52
A novel OSMR mutation in familial primary localized cutaneous amyloidosis in a British white family : P53
Psychological distress in patients with hidradenitis suppurativa : P54
Obesity, low mood, negative beliefs about illness and severity of psoriasis are linked to dysfunctional eating patterns : P55
Diurnal and seasonal variation in psoriasis symptoms : P56
An automated noninvasive method for skin-surface integrity analysis : P57
A systematic review of dermatological complications following male genital piercing : P58
Pulsed-dye laser treatment of paediatric port-wine stains: variation of practice in the U.K. National Health Service : P59
Evaluation of the relationship between aquaporin-9 and microRNA-205 expression in psoriatic epidermis : P60
Renal function in hidradenitis suppurativa: a retrospective cohort study of a tertiary-referral hidradenitis suppurativa clinic : P61
The role of beliefs, mood, coping strategies, disease severity and quality of life in patients living with psoriatic arthritis : P62
Study of transcription factor Ets-1 and adhesion molecules in vitiligo : P63
A systematic review of the impact on quality of life of interventions for psoriasis : P64
Highly sensitive C-reactive protein as a biomarker of cardiovascular risk in psoriasis : P65
Tattoos and magnetic resonance imaging: a ‘burning’ issue : P66
Noonan syndrome with multiple lentigines identified by next-generation sequencing : P67
Are we sitting on a leprosy time bomb? Where do we stand a decade after leprosy elimination in India? : P68
Should leprosy be given a backseat in the postelimination era? : P69
Pulmonary cylindromas in CYLD cutaneous syndrome : P70
A complex case of necrotizing scleritis and acne conglobata : P71
What's that smell? : P72
Senescence in dermal fibroblasts and its implication in the pathogenesis of vitiligo : P73
Comparative study of trichoscopy findings in female pattern androgenic alopecia and chronic telogen effluvium : P74
Four-year data on the use of topical immunotherapy with diphenylcyclopropenone when it all falls out: more than just a last resort : P75
Current status of observations of malignancies in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) study : P76 (PP05)
Pathological prognostic features of small-diameter melanoma : P77
Genetic and phenotypic heterogeneity in Ferguson-Smith disease: a case series : P78
Diffuse large B-cell lymphoma in mycosis fungoides and Sézary syndrome: a case series : P79
Incidence of lentigo maligna: a single health board experience, 1990-2010 : P80
Examining the consistency of diagnosis, treatment and management of spitzoid lesions : P81
Mitochondrial tolerance to single and repeat exposure to simulated sunlight in human skin cells : P82
Option grids in melanoma: improving shared decision making : P83
Neuroendocrine carcinoma in situ in association with bowenoid epidermal dysplasia and squamous cell carcinoma : P84
Skin cancer screening at the workplace in a large trading company : P85
Management of penile intraepithelial neoplasia: a retrospective observational study : P86
Pilar neurocristic hamartoma of the scalp: a case series : P87
Radiological imaging in all stage III melanomas: current practice in the U.K. : P88
Preliminary data and the design of a new U.K.-wide trial (Rational MCC) comparing surgery vs. radiotherapy as the first definitive treatment for primary Merkel cell carcinoma : P89
Improvement in the quality of life of patients with severe plaque psoriasis treated with systemic methotrexate in fixed doses of 10 mg or 25 mg orally once weekly: a prospective, randomized, double-blind, parallel-group study : P90 (PP06)
Oral antibiotics for acne: are we adopting premium use? : P91
Secukinumab achieved ≥ 90% improvement in Psoriasis Area and Severity Index at weeks 16 and 52 in many patients with no or partial response at week 12 : P92 (PP07)
A systematic review of oral anticholinergic medication in the treatment of hyperhidrosis : P93 (PP08)
A prospective study to assess the efficacy of rituximab monotherapy in severe pemphigus vulgaris and relationship between T-regulatory-cell count in peripheral blood and disease severity : P94 (PP09)
Metformin use in hidradenitis suppurativa: the experience of a tertiary-referral hidradenitis suppurativa clinic : P95 (PP10)
Systemic therapy for vulval erosive lichen planus (the ‘hELP’ Trial): a pilot randomized controlled trial : P96 (PP11)
Efficacy and safety of ixekizumab in patients with psoriasis who failed initial etanercept treatment: a subanalysis from UNCOVER 2, a randomized, double-blind, multicentre, phase III clinical trial : P97 (PP12)
Extracorporeal photopheresis in Sézary syndrome: 8-year review of data from a cutaneous T-cell lymphoma registry : P98 (PP13)
Renal dysfunction in patients taking fumaric acid esters : P99
Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients : P100
Long-term follow-up of imiquimod-treated lentigo maligna : P101
Bexarotene: a registry study of adverse effects in a population of patients with cutaneous T-cell lymphoma : P102
LIBERATE trial: sustained efficacy of apremilast in patients with moderate-to-severe psoriasis who continued on apremilast or switched from etanercept treatment : P103
Practical implications of recent recommendations for monitoring lymphocyte counts in patients with psoriasis treated with fumaric acid esters : P104
Comparative effectiveness of biological therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Study : P105
Durable response rates with talimogene laherparepvec or granulocyte-macrophage colony-stimulating factor are associated with additional clinical benefits in patients with stage IIIB-IVM1a melanoma in the OPTiM trial : P106
A novel treatment with topical timolol for drug-induced pyogenic granulomas : P107
Cost-effectiveness of apremilast in moderate-to-severe chronic plaque psoriasis: a model analysis in the U.K. : P108
Microretrodermal axillary curettage effectively reduces axillary hyperhidrosis : P109
A review of the placebo rates of response in clinical trials of hidradenitis suppurativa : P110
Dapsone effects the accuracy of glycated haemoglobin measurements and can have implications for monitoring glycaemic control or diagnosis of diabetes : P111
Secukinumab shows similar efficacy across baseline Dermatology Life Quality Index subgroups (≤ 10 or > 10) in patients with moderate-to-severe psoriasis in two pivotal phase III studies (FIXTURE and ERASURE) : P112
Uptake of influenza and pneumococcal vaccinations in patients receiving methotrexate, ciclosporin, azathioprine and biologics : P113
Order and timing of applying emollients and topical corticosteroids in atopic eczema: a survey of U.K. patients and healthcare professionals : P114
DRESS (drug reaction with eosinophilia and systemic symptoms) vs. mini-DRESS: is there a spectrum of drug hypersensitivity? : P115
Isotretinoin blood monitoring in patients with acne: creating additional expense? : P116
Lessons learnt from the design and development of a multicentre rare genetic skin disease research study : BG01
Vulvovaginal symptoms in women with epidermolysis bullosa : BG02
Genetic and phenotypic heterogeneity in Ferguson-Smith disease: a case series : BG03
Cutaneous hyperpigmentation and familial gastrointestinal stromal tumour associated with KIT mutation : BG04
Novel mutations in SLURP1 causing Mal de Meleda palmoplantar keratoderma with varying phenotypes : BG05
Mild arthrogryposis, renal dysfunction and cholestasis syndrome caused by a novel splice-site mutation in VPS33B : BG06
Tracking tumour kinetics in patients with germline CYLD mutations : BG07
FOXN1 duplication and congenital hypertrichosis: a case report : BG08
Will a genetic diagnosis of poikiloderma with neutropenia influence management? : BG09
A dramatically different case of Dowling-Degos disease : BG10
Muckle-Wells syndrome: a novel presentation : BG11
Terminal osseous dysplasia with pigmentary defects : BG12
Multiple well-differentiated squamous cell carcinomas: a case of Ferguson-Smith disease and a review of the literature for use of acitretin in this condition : BG13
Dermatologists play a key role in diagnosing LEOPARD syndrome : BG14
Brooke-Spiegler syndrome: an unusual presentation with a novel underlying mutation : BG15
An interesting case of LEOPARD syndrome : BG16
Liquid topical acrylate skin adhesive for treatment of a bleeding infantile haemangioma : BC01
Carbon dioxide laser ablation of dermatosis papulosa nigra: high patient satisfaction and few complications in patients with pigmented skin : BC02
Granuloma annulare-like response to mesotherapy : BC03
A study of combined use of microneedling and platelet-rich plasma on acne scars : BC04
Topical monobenzylether of hydroquinone for depigmentation of extensive vitiligo: a retrospective cohort study of 53 cases : BC05
Erbium:yttrium aluminium garnet laser treatment of multiple facial trichoepitheliomata in a patient with type VI skin : BC06
Spiny keratoderma of the palms treated with erbium:yttrium aluminium garnet ablation : BC07
Delayed granulomatous reaction to dermal fillers treated with intralesional triamcinolone and oral minocycline : BC08
Frontal fibrosing alopecia in men: an association with leave-on facial cosmetics sunscreens : BH01
A nail curriculum for secondary care: a review of teledermatology nail referrals received over 11 years in a specialist centre : BH02
Hair changes associated with BRAF inhibitor therapy: a case series : BH03
Clinical efficacy and tolerability of hydroxychloroquine in the treatment of lichen planopilaris: a single-centre retrospective study : BH04
Four-year data on the use of topical immunotherapy with diphenylcyclopropenone when it all falls out: more than just a last resort : BH05
Clarithromycin, rifampicin and fusidic acid combination therapy for folliculitis decalvans : BH06
Transillumination: a useful auxiliary tool for the noninvasive diagnosis of all clinical variants of digital mucous cysts : BH07
Two different cases and causes of onychoheterotopia in children : BH08
Retronychia following pregnancy : BH09
Microsporum canis presenting as female pattern hair loss in an immunosuppressed patient : BH10
Coexistence of frontal fibrosing alopecia and discoid lupus erythematosus: a true association? : BH11
Laser hair depilation: a potential treatment option for severe recalcitrant folliculitis decalvans : BH12
A rare case of spontaneous repigmentation of previously white hair : BH13
Pattern hair loss in men is not always androgenetic : BH14
Lichen planopilaris after hair transplant: a diagnostic and therapeutic challenge : BH15
A hairy conundrum: two unique cases of congenital alopecia : BH16
An unusual case of frontal fibrosing alopecia in an Asian British woman presenting with facial hyperpigmentation : BH17
Homocysteine levels in blood and the severity of vitiligo before and after narrowband ultraviolet B phototherapy : PD01
Modest response in vitiligo to excimer lamp targeted therapy, using a once-weekly dosage protocol over a 20-week treatment period : PD02
Upregulation of matrix metalloproteinase 12 and its activity by ultraviolet A1 in human skin: potential implications for human health : PD03
Cochrane systematic review: interventions in polymorphic light eruption : PD04
Factors predicting response to treatment and disease recurrence following topical photodynamic therapy for primary Bowen disease and basal cell carcinoma : PD05
Congenital erythropoietic porphyria: mild presentation with late onset associated with a uroporphyrinogen III synthase enzyme gene promoter sequence mutation : PD06
A case of photosensitive trichothiodystrophy with mutations in the ERCC2 (xeroderma pigmentosum) gene highlighting classical features and new classification : PD07
The impact of intraregional variation in ultraviolet B phototherapy protocols on psoriasis clearance : PD08
Can the Psoriasis Area and Severity Index score measured 4 weeks into a course of narrowband ultraviolet B phototherapy be used to predict final Psoriasis Area and Severity Index response? : PD09
Factors influencing pain in topical photodynamic therapy in the treatment of actinic keratosis, Bowen disease and basal cell carcinoma : PD10
Pain in photodynamic therapy: a survey of U.K. practitioners' experiences and management strategies : PD11
Mersey and North Wales regional phototherapy audit 2016 : PD12
Knowledge, behaviour and attitudes of patients with skin cancer towards national recommendations on sunlight exposure and vitamin D : PD13
Cutaneous lupus erythematosus improved by sunlight : PD14
Recurrent sun-triggered lymphocytoma on the calf with polymorphic light eruption, solar fatigue, enthesitis/polychondritis and benign follicular hyperplasia of the thymus : PD15
Four cases of intralesional blisters arising during TL01 ultraviolet B phototherapy for chronic plaque psoriasis : PD16
Proposal for National Dermatology Surgery Safety Standards: development of a dermatology surgery standard operating policy with mandatory training of staff may be an important tool to prevent wrong-site surgery : DS01
Dermatology surgery consent photo booklet enhances patient satisfaction : DS02
Preliminary data and the design of a new U.K.-wide trial (Rational MCC) comparing surgery vs. radiotherapy as the first definitive treatment for primary Merkel cell carcinoma : DS03
Feasibility of a trial investigating the management of primary cutaneous squamous cell carcinoma (SCC): Conventional vs. Mohs MIcrographic Surgery for high-risk SCC with or without Adjuvant Radiotherapy (COMMISSAR) : DS04
Final outcomes for surgical management of dermatofibrosarcoma protuberans: a 10-year review of clinical practice in the U.K. : DS05
Microretrodermal axillary curettage effectively reduces axillary hyperhidrosis : DS06
miraDry®: a novel noninvasive permanent treatment for axillary hyperhidrosis : DS07
The use of a novel 1-hour protocol for rapid frozen-section immunocytochemistry, in a case of squamous cell carcinoma treated with Mohs micrographic surgery : DS08
Advanced basal cell carcinomas treated by vismodegib and Mohs micrographic surgery: does neoadjuvant treatment have a role? : DS09
Factors associated with recurrence and metastasis in primary cutaneous squamous cell carcinoma of the pinna: a 3-year retrospective study and metaanalysis : DS10
The offset Z-plasty transposition flap: a useful option in cutaneous reconstruction : DS11
When less is more: effective outcomes of shorter single-arm advancement flaps with periosteal tacking sutures for medial canthal repair : DS12
Helical rim reconstruction utilizing a postauricular interpolation flap : DS13
A multicentre study of patient-reported outcomes in relation to Mohs micrographic surgery across two tertiary centres in the U.K. : DS14
Portable negative-pressure wound therapy for management of poorly healing wounds : DS15
Long-term follow-up of imiquimod-treated lentigo maligna : DS16
Perioperative antibiotics for patients with ulcerated skin cancers undergoing dermatological surgery in the U.K.: a nationwide survey of current clinical practice : DS17
Pulsed-dye laser and topical cantharidin for the treatment of recalcitrant cutaneous warts : DS18
Carbon dioxide laser treatment for recalcitrant viral warts: a case series : DS19
Safe treatment of truncal compensatory hyperhidrosis with high-dose botulinum neurotoxin A over 5 years : DS20
Impact of a diagnostic biopsy on the management of patients with suspected basal cell carcinomas treated with Mohs micrographic surgery : DS21
World Health Organization surgical checklist in dermatological surgery: compliance, attitudes and barriers : DS22
Increasing trend of aggressive nonmelanoma skin cancer in a young population : DS23
Medial canthal webbing following skin cancer surgery reconstruction revised with Z-plasty in 14 patients : DS24
A turnover island pedicle flap as a single-stage novel reconstructive method of deep complex defects involving the nasal vestibule and ala : DS25
Study to assess recurrence rates and patient satisfaction postradiotherapy for head and neck basal cell carcinomas : DS26
Biopsies and incomplete excisions of melanoma in primary care: a review of our audits from 2006 to 2015 : DS27
Mohs micrographic surgery is the required treatment for periocular microcystic adnexal carcinoma to maximize the possibility of tumour clearance : DS28
Mohs micrographic surgery for the treatment of vulval basal cell carcinoma : DS29
Carcinoma of the distal nasal mucosa: beware the tip of the iceberg … : DS30
Incidence and risk factors of blood splatter in dermatological surgery: need for full facial protection : DS31
A systematic review of thoracic sympathectomy to treat facial blushing : DS32
A rare case of melanoma presenting in the prostate : DS33
Does formal dermoscopy training reduce the number needed to excise in melanoma treatment? : DS34
The golden goddess of spices: a cure for Bowen disease? : DS35
Feasibility analysis to evaluate the role of perioperative antibiotics in reducing infection rates in ulcerated skin cancers : DS36
Mohs micrographic surgery: the patient experience : DS37
Hair transplantation to repair the eyebrow following Mohs micrographic surgery of basal cell carcinoma of the forehead and eyebrow : DS38
Public awareness of skin cancer: results of a large national survey in Ireland : DS39
Factors predicting complex repair following skin cancer excision : DS40
Squamous cell carcinoma developing shortly after treatment with vismodegib in a patient with multiple basal cell carcinomas : DS41
Electrosurgical resurfacing of rhinophyma: long-term follow-up, surgical outcomes and patient satisfaction : DS42
Assessment of the efficacy of follicular unit extraction in the treatment of stable vitiligo: a pilot study : DS43
Synchronous melanoma in patients with primary cutaneous malignant melanoma : DS44
Diagnostic accuracy in pigmented lesions: further supportive evidence for consultant-led dermatology skin cancer services : DS45
Complications in dermatological surgery: a single-centre experience : DS46
Patient-reported outcomes and experience of Mohs surgery: a questionnaire study : DS47
What comes through the Mohs clinic door? : DS48
A literature review assessing the benefit of sentinel lymph node biopsy in thin melanomas : DS49
Multiple basal cell carcinomas arising within port-wine stains in patients treated with thorium X : DS50
Multiple basal cell carcinomas of the nose treated by Mohs micrographic surgery in the same session and reconstruction of the resulting defects : DS51
Developing a Mohs micrographic surgery service: lessons learnt in the first 5 years : DS52
Following up patients with cutaneous squamous cell carcinoma: 5-year data from a tertiary university centre : DS53
The effect of a pigmented lesion clinic in the Mid-West of Ireland on melanoma diagnosis and management : DS54
Intraoral laser hair removal: can we call it permanent? : DS55
Excision of nonmelanoma skin cancers overlying an arteriovenous fistula : DS56
Expression of programmed death-1 in cutaneous malignant melanoma and its prognostic significance : DP01
Spectrum of granuloma annulare: a retrospective clinicopathological study : DP02
Malignant melanotic schwannian tumour: when it is just not quite right for melanoma : DP03
Review of the histology in cases of clinically diagnosed lichen sclerosus et atrophicus : DP04
Pilar neurocristic hamartoma of the scalp: a case series : DP05
Lymphoepithelioma-like carcinoma of the skin: a diagnosis to consider in the tumour clinic : DP06
Granulomatous dermatitis: a novel cutaneous side-effect of vemurafenib : DP07
Neuroendocrine carcinoma in situ in association with bowenoid epidermal dysplasia and squamous cell carcinoma : DP08
The evolution of histopathological changes in dermatitis artefacta : DP09
Two cases of panniculitis secondary to alpha-1-antitrypsin deficiency : DP10
Gryzbowski syndrome redefined: are we missing the bigger picture? : DP11
Angioinvasive lymphomatoid papulosis: a rare subtype easily mistaken for a high-grade angioinvasive lymphoma : DP12
A case of a curious itch : DP13
Myofibroma: a 10-year experience in a tertiary referral hospital : DP14
Take a second look: a challenging case of non-Langerhans cell histiocytosis : DP15
Graft-versus-host disease-associated angiomatosis in an immunosuppressed patient : DP16
Mixed immunobullous disease : DP17
Histological findings in a rare case of Omenn syndrome: case report and review of the literature : DP18
A long-standing large leg ulcer in a patient with Schöpf-Schulz-Passarge syndrome : DP19
An unusual skin malignancy : DP20
Erythema gyratum repens in association with inflammatory epidermolysis bullosa acquisita : DP21
Elastotic nodules of the ears: a forgotten differential? : DP22
Widespread tattoo sarcoidosis : DP23
Bringing Kikuchi-Fujimoto disease to light : DP24
Primary cutaneous apocrine carcinoma or metastatic breast carcinoma? : DP25
Cutaneous phaeohyphomycosis caused by Biatriospora mackinnonii in a renal transplant recipient : BI01
Cutaneous malakoplakia in an immunosuppressed patient : BI02
Fatal disseminated cowpox virus infection in an immunosuppressed adolescent : BI03
Cutaneous squamous cell carcinoma and warts in severe combined immune deficiency: a role for human papillomavirus vaccination? : BI04
Beware the rare mimicker: squamoid eccrine ductal carcinoma in a renal transplant recipient : BI05
Post-transplant lymphoproliferative disorders presenting in the skin in renal transplant recipients : BI06
Jejunal perforation: an unusual presentation of metastatic cutaneous squamous cell carcinoma in an immunosuppressed patient : BI07
Catastrophic cutaneous carcinogenesis in a renal transplant recipient : BI08
Use of biological therapy for treatment of psoriasis in HIV: a review of the evidence : BI09
Severe and refractory psoriasis associated with myelodysplastic syndrome : BI10
Graft-versus-host disease or Stevens-Johnson syndrome? Diagnostic challenges in haematopoietic stem cell transplant recipients : BI11
Intralesional bleomycin for the treatment of recalcitrant verrucae vulgaris: treatment technique and results from a U.K. centre : BI12
Patient evaluation of a dedicated dermatology service for stem cell transplant recipients using the outcomes and experiences questionnaire : BI13
Induction of antihuman papillomavirus immunity by microwave treatment of skin : BI14
A chronic wound in the setting of sclerodermoid graft-versus-host disease and radiation necrosis : BI15
Actinic cheilitis in a transplant patient successfully treated with 5% imiquimod : BI16
Two cases of lymphoma occurring during fumaric acid ester treatment of psoriasis : BI17
Florid disseminated cutaneous histoplasmosis as the initial presentation of HIV : BI18
Cutaneous tuberculosis and HIV coinfection: a case series : BI19
Primary cutaneous T-cell lymphoma post-transplant: a rare disorder and an even rarer presentation : BI20
Sun protection advice for patients with inflammatory bowel disease prescribed immunosuppressants : BI21
Lyme borreliosis in a patient on tocilizumab: a case report : BI22
Subcutaneous mycosis caused by the rare pathogen Roussoella percutanea following treatment for vascular rejection : BI23
The diverse spectrum of cutaneous cryptococcus infections after solid organ transplantation : BI24
Cryptococcosis presenting with cutaneous exophytic nodules in a renal transplant patient : BI25
Acquired epidermodysplasia verruciformis in a lung transplant recipient : BI26
Subcutaneous phaeohyphomycosis secondary to Alternaria species in a renal transplant patient : BI27
Beware the swollen leg: HIV-related Kaposi sarcoma : BI28
Rash and eosinophilia in a transplant patient : BI29
Reactivation of latent tuberculosis on ustekinumab treatment for psoriasis: a case of tuberculosis peritonitis : BI30
Aseptic splenic abscesses in association with pyoderma gangrenosum and inflammatory bowel disease : BI31
Delayed ibrutinib-induced acute eczema with positive challenge : BI32
Effectiveness and acceptability of four commonly used leave-on emollients in the treatment of childhood eczema : PA01
Intralesional measles, mumps and rubella vaccine for the treatment of multiple and recalcitrant nongenital cutaneous warts in children: a prospective, uncontrolled open-label study : PA02
Morbidity and mortality in U.K. children with recessive dystrophic epidermolysis bullosa: 16-year data from the National U.K. EB Registry : PA03
Familial BAP1 mutation presenting in a child with innocuous-looking skin lesions demonstrating a histologically distinct subtype of an atypical spitzoid tumour, and fatal paraganglioma in the father : PA04
Acitretin use in a paediatric cohort: safety and monitoring : PA05
Sustaining a paediatric dermatology service during a workforce crisis: a model of collaborative working : PA06
Noonan syndrome with multiple lentigines identified by next-generation sequencing : PA07
Twenty-year review of congenital absence of skin presenting to a paediatric dermatology department : PA08
Langerhans-cell histiocytosis: lessons from the skin : PA09
Phototherapy for paediatric dermatoses: data from a single-centre retrospective survey : PA10
Infantile atopic eczema: association with maternal tryptophan metabolite status : PA11
Fibroadipose vascular anomaly: two cases of a newly described disorder : PA12
A case on the PIK3CA -related overgrowth spectrum : PA13
A novel mutation in TGM1 causing nonbullous congenital ichthyosiform erythroderma in identical twins : PA14
Childhood psoriasis and body mass index: results from our paediatric dermatology department : PA15
Generalized lymphatic anomaly: therapeutic response to long-term low-dose sirolimus : PA16
Early recognition and detection of juvenile psoriatic arthritis: a call for a standardized approach to screening : PA17
Langerhans-cell histiocytosis presents as vulval disease in a 16-year-old girl : PA18
The presence of exaggerated mental creases: a useful marker for pseudoxanthoma elasticum in paediatric patients? : PA19
Basal cell carcinomas in paediatric and young adult patients: a series of 34 patients : PA20
Scurvy mimicking Henoch-Schönlein purpura in child with autism : PA21
Infantile generalized pustular psoriasis and its differential diagnosis : PA22
A case of Aicardi-Goutières syndrome illustrating the clinical heterogeneity of this disorder : PA23
Langerhans-cell histiocytosis: a rare case of the congenital self-healing reticulohistiocytosis or ‘Hashimoto-Pritzker’ subtype : PA24
Rickets re-emerging: a cautionary tale : PA25
Generalized telangiectasia macularis eruptiva perstans with atypical restricted diffuse cutaneous mastocytosis in a child : PA26
Linear childhood cutaneous lupus erythematosus following Blashko's lines : PA27
Case report of identical twins with Langerhans-cell histiocytosis : PA28
Occult bone pathology in McCune-Albright syndrome : PA29
Scoping the evidence of the epidemiology of childhood psoriasis : PA30
It's not always that simplex : PA31
Topical tetracyclines in the paediatric population: are they safe? A survey of British Association of Dermatologists members : PA32
Pigmented, petechial and purpuric dermatosis of infancy as postinfectious hypersensitive immunological manifestation: case report and review of the literature : PA33
Chronic cutaneous ulcer secondary to bacille Calmette-Guérin-osis caused by likely underlying Mendelian susceptibility to mycobacterial disease: case report and review of the literature : PA34
Eyelid dermatitis revisited: an evaluation of 231 patch test patients over a 3-year period : CD01
Isocyanate contact dermatitis: an unusual occupational source of exposure : CD02
Dressings: an emerging source of acrylate contact allergy : CD03
Perspectives on patch testing to pedometers, Perspex and other plastic products: inert acrylic plastics as a source of allergic contact dermatitis : CD04
Twelve-year data of contact allergy to ethylenediamine dihydrochloride: is it time to update the British Society for Cutaneous Allergy baseline series? : CD05
National U.K. patch testing data: what is the ideal proportion of the population that should be tested? : CD06
Is there a role for standardizing contact allergy testing services in England? : CD07
Photoinduced and photoaggravated allergic contact dermatitis due to methylisothiazolinone : CD08
Contact allergy to adipic acid and phthalic anhydride : CD09
Patch testing in patients with reactions to red tattoo pigment : CD10
Azathioprine does not influence the patch test reactivity in contact dermatitis to weed parthenium : CD11
Dermatology trainee contact dermatitis survey 2015 : CD12
Allergic contact dermatitis to limonene and linalool in ironing water : CD13
Occupational allergic contact dermatitis to abacavir : CD14
A cautionary tale: history of a latex and rubber accelerator allergy misinterpreted as only latex allergy during a dental procedure : CD15
Lichenoid oral eruption: a case of contact allergy to a cinnamon-flavoured toothpaste : CD16
Patch testing in pruritus ani and pruritus vulvae : CD17
Pigment-selective autoeczematization as a clue to allergic tattoo reactions : CD18
Evaluation of the effect of betamethasone on patch test reactivity in patients with contact dermatitis due to plant parthenium : CD19
To bee or not to bee? A case of contact cheilitis to bee glue and lip balm allergens : CD20
Bisulfite sensitivity masquerading as a local anaesthetic allergy : CD21
Contact allergy in children referred for patch testing : CD22
Chasing the Pot of Gold : CD23
Severe exfoliative fingertip dermatitis second to goserelin acetate, exacerbated by contact allergy to 1,6-hexanediol diacrylate : CD24
Acute generalized exanthematous pustulosis due to dextromethorphan : CD25
Tretinoin in bleaching creams: more than only an irritant? : CD26
Picture this: a local acute teledermatology service : BT01
A study evaluating the use of smartphones to photograph patients by U.K. dermatologists : BT02
Teledermatology to triage 2-week-wait referrals: a ‘real-world’ pilot study using an iPhone 5S : BT03
Teledermatology using National Health Service e-Referral: streamlining patient pathways : BT04
An innovative role of the teledermatology service: tracking an outbreak of atypical hand, foot and mouth disease in the community : BT05
The medicalization of workhouses in the 18th and 19th centuries and the development of facilities for paupers with venereal disease and ‘the itch’ : H01
Soliman's Water to Kligman's Formula: skin bleaching through the ages : H02
‘The largest mass poisoning of a population in history’ : H03
The ultimate misdiagnosis: witches' marks and dermatology in the 17th century : H04
The history of Merkel cell carcinoma : H05
The King's Evil : H06
Henri Gougerot: the arbiter of French dermatology : H07
Touching on the life and legacy of Friedrich Sigmund Merkel (1845-1919) : H08
Father Damien: the saint of lepers and pioneer of leprosy treatment : H09
‘Il sorriso di un bambino guarito ha un valore inestimabile’. The life and work of Ferdinando Gianotti (1920-1984), a pioneer in paediatric dermatology : H10
Skin disease and the emotion disgust: an historical perspective : H11
The tan: a golden or aged concept? : H12
Robert Cranston Low: artist and scientist : H13
2016: a skin odyssey : H14
‘But what is the black spot captain?’ I asked. ‘That's a summons mate’ : H15
Peeling back the years: a history of chemical peels : H16
The ‘Reading’ bacillus: a serendipitous discovery during the First World War : H17
Illustrations of infections and infestations immemorial : H18
The future for general practitioners' dermatology education: what GPs want : DT01
Does Precision Teaching enhance dermatology diagnostic skills in medical students? : DT02
A visual literacy course for dermatology trainees : DT03
Updating the curriculum content for undergraduate dermatology education : DT04
Undergraduate teaching delivery: a practical solution : DT05
Dermatology teaching to general practitioner trainees: an unmet need : DT06
Experiences of postgraduate dermatology higher specialist training: a survey of U.K. trainees : DT07
Porokeratosis vs. annular/hypertrophic lichen planus: through a dermoscope : INT01
Developing a severity scale for erythema nodosum leprosum: the ENLIST Erythema Nodosum Leprosum Severity Scale : INT02
Evaluation of the IMPACT study practitioner training intervention: using motivational interviewing to optimize self-management in psoriasis : PS01
Obesity, low mood, negative beliefs about illness and severity of psoriasis are linked to dysfunctional eating patterns : PS02
A survey of sleep disturbance in psoriasis : PS03
Acceptance and resilience in chronic skin disease: a pilot observational study : PS04
‘Not only skin deep’: an evaluation of a pilot psychodermatology service in an Irish hospital : PS05
Psychological distress in patients with hidradenitis suppurativa : PS06
The combined approach to treating atopic dermatitis : PS07
Mindfulness for eczema: a review of a small pilot group : PS08
A case series of acne excoriée: are we scratching the surface? : PS09
What's that smell? : PS10
Colour your judgement purple to avoid missing a rare diagnosis : PS11
Development and evaluation of the IMPACT programme patient resources to increase understanding of psoriasis and its management: a mixed-methods feasibility study : PS12
‘Patient’, ‘client’ or ‘service user’? A survey of preferred terms of address among those attending dermatology clinics. : PS13
Utility of patient-reported outcome measures in nonmelanoma skin cancers : PS14
‘The crucified patient’: dermatitis artefacta presenting with cruciform ulceration and deafness : PS15
A rare case of delusional infestations by proxy in two adults : PS16
Occupational notalgia paraesthetica: the curse of being tall : PS17
Histological findings in dermatitis artefacta: a case series review : PS18
A psychodermatology patient with a multitude of psychological comorbidities : PS19
More rapid improvement in quality of life with fixed-combination calcipotriene plus betamethasone dipropionate aerosol foam vs. topical suspension (PSO-ABLE study in patients with psoriasis vulgaris) : PS20